Sorry - my post didn't show, here it is (for what it's worth):
I agree with you Caketin. A high rate of T cell response is good (though it would have been interesting to have further data - I presume the response was killer T cells). Lack of antibody response (at least from the independent tests), although the Fraser group did apparently detect antibody responses, but no details how measured (ELISA, neutralising antibody .... ?). Fingers crossed for phase II.
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus announces further data from HSV-2 Trial
Ann: Admedus announces further data from HSV-2 Trial, page-113
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.80 |
Change
-0.200(1.11%) |
Mkt cap ! $341.1M |
Open | High | Low | Value | Volume |
$18.00 | $18.00 | $17.75 | $46.16K | 2.581K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 122 | $17.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.91 | 32 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 122 | 17.800 |
1 | 26 | 17.740 |
1 | 443 | 17.700 |
1 | 26 | 17.650 |
1 | 200 | 17.560 |
Price($) | Vol. | No. |
---|---|---|
17.910 | 32 | 2 |
17.930 | 51 | 2 |
17.940 | 1 | 1 |
17.950 | 270 | 2 |
18.000 | 518 | 2 |
Last trade - 13.54pm 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online